{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:37:49Z","timestamp":1781534269122,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":4870,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1017\/s1041610211000883","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T15:24:20Z","timestamp":1313421860000},"page":"S32-S40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S2","title":["Dopaminergic imaging: clinical utility now and in the future"],"prefix":"10.1016","volume":"23","author":[{"given":"Zuzana","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Rodda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610211000883_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000883_bb0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10072-003-0103-5","article-title":"123I-Ioflupane\/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","volume":"24","author":"Antonini","year":"2003","journal-title":"Neurological Science"},{"key":"10.1017\/S1041610211000883_bb0020","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000883_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiology of Aging"},{"key":"10.1017\/S1041610211000883_bb0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.57.3.278","article-title":"Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data","volume":"57","author":"Burn","year":"1994","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1017\/S1041610211000883_bb0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10072-003-0110-6","article-title":"Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease","volume":"24","author":"Ceravolo","year":"2003","journal-title":"Neurological Science"},{"key":"10.1017\/S1041610211000883_bb0040","first-page":"1065","article-title":"Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study","volume":"111","author":"Ceravolo","year":"2004","journal-title":"Journal of Neural Transmision"},{"key":"10.1017\/S1041610211000883_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00259-005-1920-y","article-title":"Quantitative simultaneous (99m)Tc-ECD\/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy","volume":"33","author":"El Fakhri","year":"2006","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1017\/S1041610211000883_bb0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ana.20088","article-title":"Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease","volume":"55","author":"Gilman","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000883_bb0055","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","article-title":"EFNS guidelines for the diagnosis and management of Alzheimer's disease","volume":"17","author":"Hort","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1017\/S1041610211000883_bb0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.55.10.1575","article-title":"18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies","volume":"55","author":"Hu","year":"2000","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000883_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1460-9568.2003.02716.x","article-title":"Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease","volume":"18","author":"Kemppainen","year":"2003","journal-title":"European Journal of Neuroscience"},{"key":"10.1017\/S1041610211000883_bb0070","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/mds.21004","article-title":"Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration","volume":"21","author":"Klaffke","year":"2006","journal-title":"Movement Disorders"},{"key":"10.1017\/S1041610211000883_bb0075","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jalz.2007.11.016","article-title":"Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography","volume":"4","author":"Koeppe","year":"2008","journal-title":"Alzheimer's Dementia"},{"key":"10.1017\/S1041610211000883_bb0080","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s004150050534","article-title":"Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration","volume":"246","author":"Laureys","year":"1999","journal-title":"Journal of Neurology"},{"key":"10.1017\/S1041610211000883_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archneur.59.1.43","article-title":"Research evaluation and prospective diagnosis of dementia with Lewy bodies","volume":"59","author":"Lopez","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000883_bb0090","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000883_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000883_bb0100","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000883_bb0105","unstructured":"National Institute for Health and Clinical Excellence (2006). National Clinical Guidance Number 42. NICE-SCIE Clinical Guideline on supporting people with dementia and their carers in health and social care. http:\/\/www.nice.org.uk\/CG42"},{"key":"10.1017\/S1041610211000883_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","article-title":"Low sensitivity in clinical diagnoses of dementia with Lewy bodies","volume":"257","author":"Nelson","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1017\/S1041610211000883_bb0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O'Brien","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610211000883_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/bjp.bp.108.052050","article-title":"Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies","volume":"194","author":"O'Brien","year":"2009","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1017\/S1041610211000883_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000051206","article-title":"The clinical picture of frontotemporal dementia: diagnosis and follow-up","volume":"10","author":"Pasquier","year":"1999","journal-title":"Dementia & Geriatric Cognitive Disorders"},{"issue":"Pt 8","key":"10.1017\/S1041610211000883_bb0130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"10.1017\/S1041610211000883_bb0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(10)70299-4","article-title":"Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management","volume":"10","author":"Piguet","year":"2011","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610211000883_bb0140","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/WNL.47.4.1065","article-title":"Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM","volume":"47","author":"Pizzolato","year":"1996","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000883_bb0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","article-title":"Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients","volume":"112","author":"Plotkin","year":"2005","journal-title":"Journal of Neural Transmission"},{"key":"10.1017\/S1041610211000883_bb0150","first-page":"1769","article-title":"PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes","volume":"47","author":"Raffel","year":"2006","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1017\/S1041610211000883_bb0155","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.58.10.1489","article-title":"Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia","volume":"58","author":"Rinne","year":"2002","journal-title":"Neurology"},{"key":"10.1017\/S1041610211000883_bb0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000105159","article-title":"Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography","volume":"4","author":"Sedaghat","year":"2007","journal-title":"Neurodegenerative Diseases"},{"key":"10.1017\/S1041610211000883_bb0165","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.10186","article-title":"Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias","volume":"51","author":"Suzuki","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610211000883_bb0170","first-page":"384","article-title":"Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis","volume":"47","author":"Van Laere","year":"2006","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1017\/S1041610211000883_bb0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000115640","article-title":"Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes","volume":"59","author":"Vlaar","year":"2008","journal-title":"European Neurology"},{"issue":"Suppl 2","key":"10.1017\/S1041610211000883_bb0180","first-page":"S754","article-title":"Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies","volume":"24","author":"Walker","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1017\/S1041610211000883_bb0185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF00841397","article-title":"Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography","volume":"24","author":"Walker","year":"1997","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1017\/S1041610211000883_bb0190","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","article-title":"Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand","volume":"73","author":"Walker","year":"2002","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1017\/S1041610211000883_bb0195","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","article-title":"Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy","volume":"78","author":"Walker","year":"2007","journal-title":"Journal of Neurology Neurosurgery & Psychiatry"},{"key":"10.1017\/S1041610211000883_bb0200","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","article-title":"Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort","volume":"70","author":"Zaccai","year":"2008","journal-title":"Neurology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224038900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224038900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610211000883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:34:02Z","timestamp":1736454842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224038900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":39,"alternative-id":["S1041610224038900"],"URL":"https:\/\/doi.org\/10.1017\/s1041610211000883","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopaminergic imaging: clinical utility now and in the future","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610211000883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}